ARKG vs SPYD
ARK Genomic Revolution ETF vs SPDR Portfolio S&P 500 High Dividend ETF
- • SPYD has the lower expense ratio at 0.07% vs 0.75% for ARKG.
- • SPYD pays a higher dividend yield (4.20%).
Side-by-side metrics
| Metric | ARKG | SPYD |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.75% | 0.07% |
Dividend yield Trailing 12-month yield. | 0.00% | 4.20% |
AUM Assets under management — bigger funds are typically more liquid. | $2.21B | $7.64B |
YTD return | 66.55% | 19.42% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 2.11 | 0.55 |
P/E ratio | — | 15.99 |
Last price | $47.17 | $49.87 |
Inception | — | — |
Issuer | ARK | State Street |
ARKG top holdings
| TWST | Twist Bioscience Corp | 8.75% |
| TXG | 10x Genomics Inc Ordinary Shares - Class A | 8.73% |
| TEM | Tempus AI Inc Class A common stock | 8.36% |
| ABSI | Absci Corp | 5.56% |
| CRSP | CRISPR Therapeutics AG | 5.22% |
| GH | Guardant Health Inc | 4.88% |
| NTRA | Natera Inc | 4.71% |
| ILMN | Illumina Inc | 4.69% |
| LLY | Eli Lilly and Co | 3.92% |
| BEAM | Beam Therapeutics Inc | 3.69% |
SPYD top holdings
| ACN | Accenture PLC Class A | 2.35% |
| HAS | Hasbro Inc | 1.71% |
| PFE | Pfizer Inc | 1.57% |
| CVX | Chevron Corp | 1.56% |
| MDT | Medtronic PLC | 1.51% |
| SWK | Stanley Black & Decker Inc | 1.48% |
| EOG | EOG Resources Inc | 1.47% |
| HPQ | HP Inc | 1.46% |
| CCI | Crown Castle Inc | 1.46% |
| AMT | American Tower Corp | 1.44% |
About ARKG
ARKG (ARK Genomic Revolution ETF) is Companies advancing genomics and molecular biology. Managed by ARK, the fund carries $2.2B in assets under management, an expense ratio of 0.75%. Its largest holding is Twist Bioscience Corp (TWST), which represents 8.7% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.
About SPYD
SPYD (SPDR Portfolio S&P 500 High Dividend ETF) is Top 80 highest-yielding S&P 500 stocks. Managed by State Street, the fund carries $7.6B in assets under management, an expense ratio of 0.07%, a dividend yield of 4.20%. Its largest holding is Accenture PLC Class A (ACN), which represents 2.4% of the portfolio. Real Estate is the fund's largest sector exposure at 24.2%.